April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Cancer-Associated Retinopathy
Author Affiliations & Notes
  • Khalid F Tabbara
    Ophthalmology, The Eye Center, Riyadh, Saudi Arabia
  • Mahmoud O Jaroudi
    Ophthalmology, The Eye Center, Riyadh, Saudi Arabia
  • Samir S Shoughy
    Ophthalmology, The Eye Center, Riyadh, Saudi Arabia
  • Haytham I Salti
    Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon
  • Footnotes
    Commercial Relationships Khalid Tabbara, None; Mahmoud Jaroudi, None; Samir Shoughy, None; Haytham Salti, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 90. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Khalid F Tabbara, Mahmoud O Jaroudi, Samir S Shoughy, Haytham I Salti; Cancer-Associated Retinopathy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):90.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To study the visual outcome and risk factors of cancer-associated retinopathy.

Methods: Three patients with sudden visual loss and normal eye exam were assessed. Each patient underwent complete eye exam including visual acuity, fundus exam, color vision, and visual fields at presentation and after therapy. Blood was obtained for anti-retinal antibodies, anti-enolase S antibodies, optic nerve auto-antibodies and recoverin antibodies. ERG, EOG, VEP, and brain MRI were also requested and helped in establishing the diagnosis. Patients were treated with steroids, mycophenolate mofetil, or both.

Results: There were 1 male and 2 female patients. Ages of the patients were 46, 59 and 33 years (mean age, 46 years). All 3 patients had positive anti-retinal antibodies. ERG and visual fields were abnormal. One patient had endometrial carcinoma and work-up following her ocular symptoms revealed distant metastases. The second patient had small cell carcinoma of the breast and underwent mastectomy and chemotherapy. The third patient had cancer associated retinopathy as the first manifestation of pinealoma which was discovered on MRI. The final visual outcome after therapy was variable. The patient with pinealoma associated retinopathy regained 20/20 vision after therapy.

Conclusions: Cancer-associated retinopathy is a rare autoimmune ocular disease that can be easily overlooked especially when the clinical eye exam is normal. It may be the main presenting manifestation of a serious systemic malignancy. Detailed history and targeted work-up including specific anti-retinal antibodies are crucial for diagnosis.

Keywords: 441 CAR • 432 autoimmune disease  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.